Holen Sie sich die Stockscreener-App
238.37
1.43%
3.37
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$235.00
Offen:
$237.2
24-Stunden-Volumen:
2.49M
Relative Volume:
0.72
Marktkapitalisierung:
$168.37B
Einnahmen:
$24.27B
Nettoeinkommen (Verlust:
$3.50B
KGV:
49.06
EPS:
4.8589
Netto-Cashflow:
$5.02B
1W Leistung:
+3.46%
1M Leistung:
+6.78%
6M Leistung:
+18.62%
1J Leistung:
+0.12%
1-Tages-Spanne:
$233.97
$238.50
1-Wochen-Bereich:
$229.28
$240.44
52-Wochen-Spanne:
$171.00
$258.23
Danaher Corp Stock (DHR) Company Profile
Firmenname
Danaher Corp
Sektor
Branche
Telefon
(202) 828-0850
Adresse
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Vergleichen Sie DHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
238.37 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
TMO
Thermo Fisher Scientific Inc
|
618.86 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
IDXX
Idexx Laboratories Inc
|
713.35 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.52 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
242.41 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2025-03-14 | Hochstufung | Stifel | Hold → Buy |
| 2025-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-31 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Eingeleitet | HSBC Securities | Hold |
| 2023-12-13 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2023-12-07 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-01 | Eingeleitet | SVB Securities | Outperform |
| 2023-04-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-10-24 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-17 | Fortgesetzt | Bernstein | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-06-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Eingeleitet | Bernstein | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-10 | Bestätigt | BofA Securities | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Buy |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-04-07 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-03 | Fortgesetzt | Barclays | Overweight |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Fortgesetzt | Stifel | Hold |
| 2019-10-28 | Bestätigt | Needham | Buy |
| 2019-10-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-19 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2019-02-25 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-04-20 | Bestätigt | Stifel | Buy |
Alle ansehen
Danaher Corp Aktie (DHR) Neueste Nachrichten
Danaher Corporation $DHR Shares Sold by SG Americas Securities LLC - MarketBeat
Rothschild Investment LLC Purchases 6,380 Shares of Danaher Corporation $DHR - MarketBeat
Nisa Investment Advisors LLC Has $39.48 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Holdings Cut by Strategic Blueprint LLC - MarketBeat
Zacks Research Has Weak Outlook for Danaher FY2025 Earnings - MarketBeat
Danaher Corporation $DHR Shares Sold by Commonwealth Equity Services LLC - MarketBeat
Agilent Technologies: Why Execution Matters Most When the Cycle Turns - Investing.com
Is Danaher Corporation stock a buy in volatile marketsQuarterly Investment Review & AI Driven Stock Reports - ulpravda.ru
Is Danaher Corporation stock trading at a premium valuation2025 Retail Activity & Precise Swing Trade Alerts - ulpravda.ru
Danaher Corp. Stock: Silent Monster Move Or Overhyped Snoozefest? - AD HOC NEWS
Promising Biotech Stocks To ConsiderJanuary 4th - MarketBeat
Buy Danaher Stock. It’s Ready to Put Post-Covid Malaise Behind It. - Barron's
Robeco Institutional Asset Management B.V. Increases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Cerity Partners LLC Lowers Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (NYSE:DHR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings - TechStock²
$1000 Placed in Danaher a Decade Ago Would Be Valued at This Amount Now - Bitget
Where Danaher Stands With Analysts - Benzinga
DHR: TD Cowen Raises Price Target to $270, Maintains "Buy" Ratin - GuruFocus
Danaher (NYSE:DHR) Price Target Raised to $270.00 - MarketBeat
What insider purchases suggest about Danaher Corporation stockInstitutional Buying Trends & Ride the Trends That Billionaires Follow - ulpravda.ru
Danaher Corporation $DHR Shares Sold by Sivik Global Healthcare LLC - MarketBeat
MassMutual Private Wealth & Trust FSB Sells 68,082 Shares of Danaher Corporation $DHR - MarketBeat
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Here's What to Expect From Danaher's Next Earnings Report - Barchart.com
Is Danaher (DHR) Pricing In Too Much Optimism After Recent Steady Share Performance - Yahoo Finance
Biotech Stocks To Watch TodayJanuary 3rd - MarketBeat
Assessing Danaher (DHR) Valuation As The Business Refocuses On Life Sciences And Diagnostics - simplywall.st
Greenleaf Trust Has $15.47 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Top Biotech Stocks To Watch NowJanuary 2nd - MarketBeat
Danaher’s CEO takes the stage at J.P. Morgan healthcare conference in SF - Stock Titan
Guggenheim Raises Price Target on DHR to $275, Maintains Buy Rat - GuruFocus
Panic Selling: Is Danaher Corporation stock a defensive play in 2025July 2025 Price Swings & Verified High Yield Trade Plans - moha.gov.vn
Danaher’s Push Into Higher‑Margin Life Sciences Might Change The Case For Investing In DHR - simplywall.st
Danaher Corp (NYSE:DHR) Shows Technical Breakout Setup with Strong Trend and Base Formation - Chartmill
Railway Pension Investments Ltd Boosts Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (DHR) Stock Analysis: Evaluating a Strong Buy with 12.51% Upside Potential - DirectorsTalk Interviews
Danaher Corporation $DHR Stake Boosted by Capital Advisors Inc. OK - MarketBeat
Best sustainable companies to own in 2026 - Morningstar Australia
Danaher Corp Is Quietly Eating Wall Street — Are You Sleeping On DHR? - AD HOC NEWS
Guggenheim Boosts Danaher (NYSE:DHR) Price Target to $275.00 - MarketBeat
JARISLOWSKY FRASER Ltd Lowers Stake in Danaher Corporation $DHR - MarketBeat
GAM Holding AG Acquires 9,081 Shares of Danaher Corporation $DHR - MarketBeat
Altfest L J & Co. Inc. Sells 5,124 Shares of Danaher Corporation $DHR - MarketBeat
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - Business Wire
Single-Use Bioprocessing Products Market Set to Reach USD 36 - openPR.com
Bank Pictet & Cie Europe AG Increases Holdings in Danaher Corporation $DHR - MarketBeat
Ascent Group LLC Acquires 5,422 Shares of Danaher Corporation $DHR - MarketBeat
Vanderbilt University Takes Position in Danaher Corporation $DHR - MarketBeat
Allspring Global Investments Holdings LLC Raises Stock Holdings in Danaher Corporation $DHR - MarketBeat
Best Biotech Stocks To ConsiderDecember 29th - MarketBeat
Finanzdaten der Danaher Corp-Aktie (DHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.04%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):